Calmare Therapeutics Inc (fka CTTC)

[nobodysbusiness]

Wow! Doesn't this tell you everything you need to know:

"Training payments and the sale of supplies i.e., electrodes and cables for use with our Calmare® devices 2016 $23,000 2015 $43,000"

And they further specify that the change was "primarily because of a decline in training revenue."

So once the device is sold, not only can CTTC not count on training generating further revenue, apparently the demand for supplies -- the one thing that would generate recurring income -- is pretty much stagnant.

The lack of demand for supplies itself suggests a corresponding lack of demand for the treatment.